Systemic sclerosis from autoimmunity to alloimmunity

Southern Medical Journal

Volumn 92, Issue 5, 1999, Pages 472-476

  Famularo, Giuseppe ^a   De Simone, Claudio ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN;

ALLOIMMUNITY; ARTICLE; AUTOIMMUNITY; BLOOD GROUP INCOMPATIBILITY; DATA BASE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; MEDICAL INFORMATION; MICROCHIMERISM; PATHOGENESIS; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; CHIMERA; FEMALE; FETUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; ISOANTIGENS; PREGNANCY; PREGNANCY COMPLICATIONS; SCLERODERMA, SYSTEMIC;

EID: 0032896879     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199905000-00004     Document Type: Article

References (39)

1. Nelson JL: Pregnancy immunology and autoimmune disease. J Reprod Med 1998; 43:335-340
2. Chosidow O, Bagot M, Vernant J-P, et al: Sclerodermatous chronic graft-versus-host disease: analysis of seven cases. J Am Acad Dermatol 1992; 26:49-55
3. Janin-Mercier A, Devergie A, van Cauwenberg D, et al: Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man. Am J Pathol 1984; 115:296-306
4. Bell SA, Faust H, Mittermuller J, et al: Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol 1996; 134:848-854
5. Bianchi DW: Prenatal diagnosis by analysis of fetal cells in maternal blood. J Pediatr 1995; 127:847-856
6. Steele CD, Wapner RJ, Smith JB, et al: Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clin Obstet Gynecol 1996; 39:801-813
7. Gill TJ III: Chimerism in humans. Transplant Proc 1977; 9:1423-1431
8. Lo YMD, Lo ESF, Watson N, et al: Two-way traffic between mother and fetus: biological and clinical implications. Blood 1996; 88:4390-4395
9. Hall JM, Lingenfelter P, Adams SL, et al: Detection of maternal cells in umbilical cord blood using fluorescence in situ hybridization. Blood 1995; 86:2829-2832
10. Bianchi DW, Zickwolf GK, Weil GJ, et al: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93:705-708
11. O'Reilly RJ, Patterson JH, Bach FH, et al: Chimerism detected by HL-A typing. Transplantation 1973; 15:505-507
12. Bassukas ID: Is erythema toxicum neonatorum a mild self-limited acute cutaneous graft-versus-host-reaction from maternal-to-fetal lymphocyte transfer? Med Hypotheses 1992; 38:334-338
13. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482
14. Famularo G, Procopio A, Giacomelli R, et al: Soluble interleukin-2 receptor, interleukin-2, and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 1990; 81:368-372
15. Hasegawa M, Fujimoto M, Kikuchi K, et al: Elevated serum levels of interleukin-4 (IL-4), IL-10 and IL-13 in patients with systemic sclerosis. J Rheumatol 1997; 24:328-332
16. Mavalia C, Scaletti C, Romagnani P, et al: Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997; 151:1751-1758
17. Famularo G, Giacomelli R, Alesse E, et al: Polyclonal B lymphocyte activation in patients with progressive systemic sclerosis. J Clin Lab Immunol 1989; 29:59-63
18. Silman AJ, Black C: Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis 1988; 47:441-444
19. Black CM, Stevens WM: Scleroderma. Rheum Dis Clin North Am 1989; 15:193-212
20. Nelson JL: Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996; 39:191-194
21. Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338:1186-1191
22. Nelson JL, Furst DE, Maloney S, et al: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351:559-562
23. Artlett CM, Welsh KI, Black CM, et al: Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1998; 47:17-22
24. McMilin KD, Johnson RL: HLA homozigosity and the risk of related-donor transfusion-associated graft-versus-host disease. Transfus Med Rev 1993; 7:37-41
25. Bonney EA, Matzinger P: The maternal immune system's interaction with circulating fetal cells. J Immunol 1997; 158:40-47
26. Shulman HM, Sullivan KM: Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. Concepts Immunopathol 1988; 6:141-165
27. Portanova JP, Claman HN, Kotzin BL: Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA. J Immunol 1985; 135:3580-3586
28. Schurmans S, Merino J, Qin HY, et al: Autoimmune syndrome after neonatal induction of tolerance to alloantigens: analysis of the specificity and of the cellular and genetic origin of autoantibodies. Autoimmunity 1991; 9:283-291
29. de la Hera M, de la Hera A, Ramos A, et al: Self-limited autoimmune disease related to transient donor B cell activation in mice neonatally injected with semi-allogeneic cells. Int Immunol 1992; 4:67-74
30. Piotrowski P, Croy BA: Maternal cells are widely distributed in murine fetuses in utero. Biol Reprod 1996; 54:1103-1110
31. Pollack MS, Kirpatrick D, Kapoor N, et al: Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982; 307:662-666
32. Hutchinson DL, Turner JH, Schlesinger ER: Persistence of donor cells in neonates after fetal and exchange transfusion. Am J Obstet Gynecol 1971; 109:281-284
33. Brubaker DB: Immunopathogenic mechanisms of post-transfusion graft-vs-host disease. Proc Soc Exp Biol Med 1993; 202:122-147
34. Juji T, Takahashi K, Shibata Y, et al: Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med 1989; 321:56
35. Thomas MR, Williamson R, Craft I, et al: Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994; 343:413-414
36. Englert H, Brennan P, McNeil D, et al: Reproductive function prior to disease onset in women with scleroderma. J Rheumatol 1992; 19:1575-1579
37. Caillet-Zuchman S, Legrande C, Suberielle C, et al: Microchimerism frequency two to thirty years after cadaveric kidney transplantation. Hum Immunol 1994; 41:91-95
38. Sivasai KS, Alevy YG, Duffy BF, et al: Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor specific chimerism. Transplantation 1997; 64:427-432
39. Rapanotti MC, Arcese W, Buffolino S, et al: Sequential monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation. Bone Marrow Transplant 1997; 19:703-707